NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, 2025, NMD4C proudly hosted its first Clinical Summer School in Ottawa, ON, welcoming 19 neuromuscular clinical fellows from institutions across the country. Co-chaired by Dr. Gordon Jewitt and Dr. Marianne Nury, the event marked a significant milestone in national efforts to foster excellence in neuromuscular care and education.

The immersive two-day program featured interactive, hands-on workshops led by Canadian experts, including Drs. Alberto Aleman, Grayson Beecher, Ari Breiner, Leslie Hamilton, Hanns Lochmüller, Hugh McMillan, Gerd Melkus, Kiran Polavarapu, Zaeem Siddiqi, and Jodi Warman Chardon. These sessions were designed to complement NMD4C’s Royal College–accredited National Neuromuscular Lecture Series, offering fellows a unique opportunity to refine diagnostic and analytical skills in a collaborative setting.

In addition to clinical training, the Summer School emphasized mentorship and peer connection. A dedicated networking session on Day 1 allowed fellows to build relationships and share experiences, reinforcing the network’s commitment to community-building among early-career researchers.

A highlight of the event was the peer election of Dr. Joaquín Machado and Dr. Bridget Mulvany-Robbins as Co-Chief Neuromuscular Fellows. We also extend our thanks to Dr. Zahra Aleisa for her outstanding service and leadership as our 2024/2025 Chief Neuromuscular Fellow. Her commitment has been instrumental in shaping a supportive and enriching environment for fellows across the network.

To ensure accessibility, NMD4C waived registration fees and provided travel and accommodation support, enabling participation from across Canada. We would like to extend our thanks to our sponsors FUJIFILM Sonosite and CANON Medical, as well as all speakers, fellows, and partners whose contributions made the event a resounding success.

By investing in the next generation of neuromuscular specialists, NMD4C continues to advance its mission of collaborative research, clinical excellence, and national capacity-building in neuromuscular medicine.

Relive the highlights from this event

2025 Clinical Summer School

Read next...

NMD4C Talent Pool

Discover Neuromuscular Talent Across Canada

The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.

2026 NMD4C Annual Meeting Registration is Open

Join Us at the 2026 NMD4C Annual Meeting on 25 September

The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.

BSTC Icon - Light Background

Introducing Our New SOP on Skeletal Muscle Fiber Typing

We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,” developed by from our Basic Science Trainee Committee (BSTC) member Shatha Atieh, Phd Student at uOttawa. This SOP aims to provide a comprehensive, step-by-step protocol for staining and analyzing skeletal muscle fibers from any muscle group in various mouse models. This new SOP provides detailed methods for immunofluorescence‑based fiber typing using MyHC‑I, MyHC‑IIA, MyHC‑IIB, and laminin, enabling accurate assessment of fiber‑type composition and cross‑sectional area (CSA).